1585 related articles for article (PubMed ID: 25810047)
21. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
Barletta JA; Nosé V; Sadow PM
Endocr Pathol; 2021 Mar; 32(1):35-43. PubMed ID: 33492588
[TBL] [Abstract][Full Text] [Related]
22. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma.
Heshmati HM; Gharib H; van Heerden JA; Sizemore GW
Am J Med; 1997 Jul; 103(1):60-9. PubMed ID: 9236487
[TBL] [Abstract][Full Text] [Related]
23. Multiple endocrine neoplasia type 2: 2007 update.
Raue F; Frank-Raue K
Horm Res; 2007; 68 Suppl 5():101-4. PubMed ID: 18174721
[TBL] [Abstract][Full Text] [Related]
24. RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients.
Sharma BP; Saranath D
J Biosci; 2011 Sep; 36(4):603-11. PubMed ID: 21857107
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and genetic profile of patients with medullary thyroid cancer treated in the Cancer Centre--Institute of Oncology in Warsaw].
Czetwertyńska M; Kozłowicz-Gudzińska I; Stachlewska-Nasfeter E; Sromek M; Skasko E; Paszko Z
Endokrynol Pol; 2006; 57(4):415-9. PubMed ID: 17006846
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Kambouris M; Jackson CE; Feldman GL
Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
[TBL] [Abstract][Full Text] [Related]
27. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
28. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
Niederle B; Sebag F; Brauckhoff M
Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
[TBL] [Abstract][Full Text] [Related]
29. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
[TBL] [Abstract][Full Text] [Related]
30. Management of hereditary medullary thyroid carcinoma.
Pappa T; Alevizaki M
Endocrine; 2016 Jul; 53(1):7-17. PubMed ID: 26839093
[TBL] [Abstract][Full Text] [Related]
31. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Wohllk N; Cote GJ; Evans DB; Goepfert H; Ordonez NG; Gagel RF
Endocrinol Metab Clin North Am; 1996 Mar; 25(1):1-25. PubMed ID: 8907678
[TBL] [Abstract][Full Text] [Related]
32. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
33. [Medullary carcinoma of the thyroid: diagnosis and therapy].
Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
[TBL] [Abstract][Full Text] [Related]
34. Medullary thyroid cancer: management guidelines of the American Thyroid Association.
; Kloos RT; Eng C; Evans DB; Francis GL; Gagel RF; Gharib H; Moley JF; Pacini F; Ringel MD; Schlumberger M; Wells SA
Thyroid; 2009 Jun; 19(6):565-612. PubMed ID: 19469690
[TBL] [Abstract][Full Text] [Related]
35. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002.
Kameyama K; Takami H
Endocr J; 2004 Oct; 51(5):453-6. PubMed ID: 15516777
[TBL] [Abstract][Full Text] [Related]
37. [Results of treating medullary thyroid carcinoma: the differences between sporadic and inherited forms].
Wygoda Z; Włoch J; Gubała E; Wiench M; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():422-31. PubMed ID: 12182060
[TBL] [Abstract][Full Text] [Related]
38. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
Krampitz GW; Norton JA
Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
[TBL] [Abstract][Full Text] [Related]
39. Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma.
Lairmore TC; Frisella MM; Wells SA
Ann Med; 1996 Oct; 28(5):401-6. PubMed ID: 8949970
[TBL] [Abstract][Full Text] [Related]
40. Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report.
Unruh A; Fitze G; Jänig U; Bielack S; Lochbühler H; Coerdt W
J Pediatr Surg; 2007 Sep; 42(9):1623-6. PubMed ID: 17848262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]